Dr Reddy terminates Armis Biopharma's investigation license of DFA-02
Hyderabad: Dr. Reddy’s Laboratories Ltd. has announced the termination of the license granted to Armis Biopharma, Inc. (formerly known as CHD Bioscience, Inc.) for its investigational antibacterial product, DFA-02, for the prophylaxis of surgical site infections (SSIs).
As a result of the termination, Dr. Reddy's has regained worldwide rights to DFA-02 and is currently evaluating its options to take the program forward.
DFA-02 is a combination, broad-spectrum antibacterial in situ gel which is being investigated for the prophylaxis of SSIs as an adjunct to conventional preoperative antibiotic prophylaxis. DFA-02 has been studied in several phases 1 and 2 clinical studies and has demonstrated clinical efficacy in several key segments of patients who were at high risk for SSIs.
As a result of the termination, Dr. Reddy's has regained worldwide rights to DFA-02 and is currently evaluating its options to take the program forward.
DFA-02 is a combination, broad-spectrum antibacterial in situ gel which is being investigated for the prophylaxis of SSIs as an adjunct to conventional preoperative antibiotic prophylaxis. DFA-02 has been studied in several phases 1 and 2 clinical studies and has demonstrated clinical efficacy in several key segments of patients who were at high risk for SSIs.
antibiotic prophylaxisArmis BiopharmaCHD BioscienceDFA-02Dr ReddyDr Reddy's LaboratoriesSSIsurgical site infections
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd